Tekla Capital Management LLC Acquires Shares of 35,233 Pliant Therapeutics, Inc. (NASDAQ:PLRX)

Tekla Capital Management LLC acquired a new stake in Pliant Therapeutics, Inc. (NASDAQ:PLRX – Get Rating) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm acquired 35,233 shares of the company’s stock, valued at approximately $681,000. Tekla Capital Management LLC owned approximately 0.07% of Pliant Therapeutics […]

Related Keywords

United States ,Mike Ouimette ,Bernard Coulie ,Zurcher Kantonalbank Zurich Cantonalbank ,Tekla Capital Management ,Pliant Therapeutics Inc ,Securities Exchange Commission ,Cantor Fitzgerald ,Needham Company ,Acadian Asset Management ,Blackstone Inc ,Tower Research Capital ,Citigroup ,Nasdaq ,Pliant Therapeutics ,Get Rating ,Capital Management ,Asset Management ,Research Capital ,Kantonalbank Zurich Cantonalbank ,General Counsel Mike Ouimette ,Pliant Therapeutics Daily ,Nasdaq Plrx ,Plrx ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,